Prevail Therapeutics
Clinical trials sponsored by Prevail Therapeutics, explained in plain language.
-
Spinal injection trial seeks to slow Parkinson's progression
Disease control Recruiting nowThis early-stage study is testing the safety and drug levels of a new medication, LY3962681, delivered by injection into the spinal fluid. It involves healthy volunteers and people with mild to moderate Parkinson's disease. The main goal is to see if the treatment is safe and how…
Phase: PHASE1 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
One-Shot gene therapy trial offers hope for gaucher disease patients
Disease control Recruiting nowThis early-stage study is testing a single intravenous dose of an experimental gene therapy called LY3884961 in adults with Gaucher disease. The main goal is to see if the treatment is safe and tolerable, while also checking if it can improve key disease measures like spleen size…
Phase: PHASE1, PHASE2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC